Profile Picture
Rewards
  • All
  • Chat
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

'Never be the same'
Michael Gambon dies at 82
Remains found after 3 years
Suffers heart attack on stage
Alcohol ban for US workers
Gives birth to first child
Lends NYC home to Turner?
Airlines 'went too far’: CEO
'Having children saved me'
Michael Bonallack dies
Ghost guns found at day care
Teen stabs teachers, pupil
Taiwan's new submarine
Brain surgery using AI?
NY bans facial recognition
'AGT' season 18 winner
To resume negotiations
AL Rep. Rogers indicted
Gold bars sell like hot cakes
2-yr extension, named captain
$1.5M statue recovered
Harvest Moon 2023
Haiti gang violence grows
6 slain teens found in MX
Storm Elias crashes Greece
Paris bike-lane traffic jams
Swift inspired condiment
Heated tobacco device launch
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
222,000 results
News4Jax
2h
First FDA approved drug to slow Alzheimer’s
More than six million Americans are living with Alzheimer’s disease – it slowly steals your memories and takes away your mind ...
15m
FDA advisers vote against experimental ALS treatment pushed by patients
The panel of Food and Drug Administration experts voted 17-1 that drugmaker Brainstorm’s stem cell-based treatment has not ...
朝日新聞社9d
Alzheimer’s drug Leqembi has full FDA approval
Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 ... WASHINGTON--U.S. officials granted full approval to a closely watched Alzheimer’s drug on ...
The Courier-Journal8d
Delaying Alzheimer's: Norton begins administering new drug to slow dementia progression
Every two weeks, Pam Jeffries settles into an armchair and waits for an infusion of a groundbreaking treatment for her memory loss. The new drug, which was approved by the FDA earlier this year ...
Afro16d
Why is Medicare rationing Alzheimer’s drugs?
The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer’s disease, a scourge that claims more American lives than breast cancer and prostate cancer combined.
Medical Xpress26d
Unlocking how the new Alzheimer's drug lecanemab works
Approved by the FDA earlier this year, the Alzheimer's therapy lecanemab is an antibody that reduces the buildup in the brain of a sticky peptide called amyloid-beta (Aβ), which is thought to be ...
1hon MSN
2 accused of false Alzheimer’s diagnoses get prison terms for fraud convictions
A former director of an Ohio memory-loss clinic accused by dozens of patients of falsely diagnosing them with Alzheimer’s disease has been sentenced on federal fraud charges, along with her physician ...
The Financial Times25d
Vivek Ramaswamy’s FDA ‘corruption’ claims disavowed by Roivant
We’ll send you a myFT Daily Digest email rounding up the latest Vivek Ramaswamy news every morning. US biotech company Roivant Sciences has moved to distance itself from its founder, Vivek ...
Salon14d
Navigating new Alzheimer's drugs can be confusing and expensive. So do they really help patients?
For decades, attempts to treat or slow Alzheimer's disease (AD) — a brain disorder that causes dementia through damage to brain cells and other changes in the brain — have been dispiriting ...
The Boston Globe28d
Drug firms test medicines to halt Alzheimer’s before symptoms appear
Alzheimer’s disease has killed at least three women in Astrida Schaeffer’s family over two generations, leaving her feeling helpless and bereft. The first was her Polish-born maternal ...
WISH-TV
13h
Health Spotlight: First FDA-approved drug to slow Alzheimer’s
More than 6,000,000 Americans are living with Alzheimer's disease – it slowly steals your memories and takes away your mind ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices